---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-019500"
form_type: "8-K"
ticker: null
cik: "0001642375"
company_name: "Guardion Health Sciences, Inc."
filed_at: "2023-05-30T23:59:59+00:00"
generated_at: "2026-06-14T11:44:46.563990+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Guardion Health Sciences appoints Jan Hall as CEO; Bret Scholtes resigns effective June 9, 2023

## Summary
- Bret Scholtes resigns as President, CEO, and director effective June 9, 2023; no disagreement with company.
- Jan Hall appointed President and CEO effective June 19, 2023; former Neutrogena North America President and Coca-Cola SVP.
- Hall's employment: $370,000 base salary, target bonus up to 100% of base, severance up to 12 months.
- Board reduced from five to four directors effective June 10, 2023.

## SEC filing metadata
- accession: 0001493152-23-019500
- form_type: 8-K
- cik: 0001642375
- company_name: Guardion Health Sciences, Inc.
- filed_at: 2023-05-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-019500
- JSON: https://secwatch.observer/filing/0001493152-23-019500.json
- Plain text: https://secwatch.observer/filing/0001493152-23-019500.txt

## Key facts
- Executive change
  Bret Scholtes resigned as President and Chief Executive Officer at Guardion Health Sciences, Inc..
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: accepted the resignation of Bret Scholtes, the Company’s President and Chief Executive Officer, effective as of June 9, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm
- Executive change
  Janet Hall was appointed as President and Chief Executive Officer at Guardion Health Sciences, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: Effective as of June 19, 2023, the Company appointed Janet (“Jan”) Hall as the Company’s President and Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.